Company intelligence / Profile preview

AccelLAB

Boisbriand, Quebec, Canadaaccellab.com ↗

Ownership: Private
Employees: ~100
Development stage: Other

Overview

AccelLAB specializes in providing high-quality GLP-compliant safety and efficacy studies for medical devices, biologics, and pharmaceuticals. The company supports proof-of-concept through regulatory submission with advanced imaging modalities, histopathology, clinical pathology labs, and a large vivarium. It has particular expertise in cardiology and orthopedics but serves a broad range of device categories. The company was acquired by CiToxLAB in November 2016 to expand its global CRO capabilities.

Therapeutic areas: DermatologyCardiovascularOther
Modalities: Device (Medical device testing and evaluation)Biologic (Biotechnology preclinical studies)Small molecule (Pharmaceutical preclinical studies, as part of broader CRO services)
Industry: Contract Research Organization

Partnerships

Not specified; works with global medical device manufacturers as clients.

Beyond the preview

Go deeper on AccelLAB.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AccelLAB.

Explore the full profile